The balance between acetylation and deacetylation of histone and nonhistone proteins controls gene expression in a variety of cellular processes, with transcription being activated by acetyltransferases and silenced by deacetylases. We report here the formation and enzymatic characterization of a complex between the acetyltransferase p300 and histone deacetylases. The C/H3 region of p300 was found to co-purify deacetylase activity from nuclear cell extracts. A prototype of class I histone deacetylases, HDAC1, interacts with p300 C/H3 domain in vitro and in vivo. The p300-binding protein E1A competes with HDAC1 for C/H3 binding; and, like E1A, HDAC1 overexpression interferes with either activation of Gal4p300 fusion protein or p300-dependent co-activation of two C/H3-binding proteins, MyoD and p53. The exposure to deacetylase inhibitors could reverse the dominant-negative effect of a C/H3 fragment insulated from the rest of the molecule, on MyoD-and p53-dependent transcription, whereas inhibition by E1A was resistant to trichostatin A. These data support the hypothesis that association between acetyltransferases and deacetylases can control the expression of genes implicated in cellular growth and differentiation, and suggest that the dominant-negative effect of the p300 C/H3 fragment relies on deacetylase recruitment.
Introduction
Acetylation and deacetylation of both histones and nonhistone proteins have emerged as nodal point in regulating transcription (Kouzarides, 2000; Sterner and Berger, 2000; Strahl and Allis, 2000) , and proteins with intrinsic deacetylase and acetyltransferase activities are of the utmost importance in controlling cellular processes influenced by gene expression (Howe et al., 1999; Cress and Seto, 2000; Grozinger and Schreiber, 2002) .
A number of proteins with intrinsic acetyltransferase activity have been identified in the last years, including p300 and CBP (Bannister and Kouzarides, 1996; Ogryzko et al., 1996) , formerly defined as large transcriptional adaptors connecting transcription factors with the basal transcription machinery (Janknecht and Hunter, 1996; Dallas et al., 1997) and targeted by the adenoviral oncoprotein E1A (Whyte et al., 1989; Arany et al., 1995; Lundblad et al., 1995) . p300 and CBP (collectively referred to as p300/CBP) associate with DNA sequence-specific transcription factors involved in regulating cellular functions (Goodman and Smolik, 2000) , such as terminal differentiation of skeletal muscle and other cell types, and cell cycle arrest or apoptosis induced by DNA damage (Giordano and Avantaggiati, 1999; Puri and Sartorelli, 2000; Chan and La Thangue, 2001; Sartorelli and Puri, 2001 ). Recruitment of acetyltransferases by MyoD or other muscle-regulatory factors (MRFs) during myogenic differentiation, and by p53-and p73, following exposure to genotoxic stress, correlates with hyperacetylation of these transcription factors as well as of histones surrounding their binding sites (Gu and Roeder, 1997; Sakaguchi et al., 1998; Sartorelli et al., 1999; Polesskaya et al., 2000; Costanzo et al., 2002) .
A 12-amino-acid transcription adapter motif (TRAM) within the C/H3 region is conserved among p300 and CBP from different species and is necessary for the interaction with multiple DNA-binding factors (O'Connor et al., 1999) , including the transcriptional activators MyoD and p53 (Eckner et al., 1996; Yuan et al., 1996; Avantaggiati et al., 1997; Sartorelli et al., 1997) , as well as additional co-activators, such as PCAF (Yang et al., 1996) . Furthermore, the C/H3 domain interacts with the elements of the basal transcription machinery (e.g. RNA pol II, TFIIB) and with RNA helicase A (Nakajima et al., 1997; Cho et al., 1998; Kim et al., 1998; Felzien et al., 1999) . Nonetheless, the C/H3 region also recruits negative regulators of MyoD-and p53-mediated transcription, such as E1A and Twist (Yang et al., 1996; Chakravarti et al., 1999; Hamamori et al., 1999) . Notably, while the p300/CBP-binding protein PCAF provides an additional and nonredundant HAT activity (Yang et al., 1996; Puri et al., 1997a; Sakaguchi et al., 1998; Sartorelli et al., 1999) , E1A and Twist inhibit p300/CBP HAT activity (Chakravarti et al., 1999; Hamamori et al., 1999) . Furthermore, PCAF and E1A compete for the same interaction surface within the C/H3 domain (Yang et al., 1996) , whereas MyoD and p53 appear to bind regions of the C/H3 domain that are distinct, albeit partially overlapping, from the PCAF-and E1A-interacting domain Puri et al., 1997a) . Thus, the C/H3 domain (or immediate flanking regions) appears to integrate a variety of cues by assembling either activatory or repressory multiprotein complexes. Remarkably, the C/H3 region of p300/CBP, when insulated from the rest of the molecule, can exert a dominant-negative effect over the endogenous p300 and CBP, upon its ectopic expression (Yuan et al., 1996; Avantaggiati et al., 1997; Puri et al., 1997b) .
Histone deacetylases (HDACs) have been identified as transcriptional repressors by virtue of their ability to deacetylate histones (Grozinger and Schreiber, 2002) . They are subdivided into three distinct subgroups, based on the differences in structure and regulation (Khochbin et al., 2001) . HDAC1 was first identified as a trapoxin (deacetylase inhibitor)-binding protein (Taunton et al., 1996) , and subsequently shown to be a growth factorinduced protein that associates with the repressory nuclear receptor complex and methylated CpG-dependent MeCP2-silencing complex (Bartl et al., 1997; Bird and Wolffe, 1999) . Further studies have led to the identification of HDAC1 as a mediator of transcriptional repression by pRb and other pocket proteins on E2F activity during cell cycle arrest and differentiation (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998; Stiegler et al., 1998; Iavarone and Massague, 1999) . Recent reports have shown that deacetylases, such as HDAC family members, also counteract the activity of transcriptional activators implicated in cellular differentiation, nuclear hormone receptordependent transcription and responses to genotoxic agents (Cress and Seto, 2000; McKinsey et al., 2001; Sartorelli and Puri, 2001; Wade, 2001) . Deacetylation of MyoD and p53 mediates their functional inactivation (Luo et al., 2001; Mal et al., 2001; Puri et al., 2001) , and specific inhibitors of histone deacetylases such as trichostatin A (TSA), valproic acid (VPA) and sodium butyrate can cause growth arrest and differentiation in a variety of cancer cell types in vitro and promote skeletal muscle differentiation (Archer and Hodin, 1999; Iezzi et al., 2002) .
A dynamic equilibrium between deacetylation and acetylation would warrant the control of distinct patterns of transcription at different cellular stages. This equilibrium implicates the simultaneous presence of both acetyltransferases and deacetylases on the same gene regulatory loci. This hypothesis is substantiated by the widely observed effect of deacetylase inhibitors, whose exposure causes both general and local histone hyperacetylation (Richon et al., 2000; Eberharter and Becker, 2002; Iezzi et al., 2002) . We hypothesized that a direct cross-talk between the effectors of these two opposing enzymatic activities might be an efficient way to regulate gene transcription, and therefore decided to investigate whether deacetylases and acetyltransferases can associate in one complex. We provide experimental support for a model in which deacetylase activity is recruited by the C/H3 region of p300 and, in functional analogy to the viral protein oncogene E1A, antagonizes p300 activity.
Results and discussion
Histone acetylation within promoters fluctuates, often as a result of rapid changes in the activity of enzymes with opposite functions that regulate this process. An overall histone hyperacetylation following exposure to deacetylase inhibitors has been observed at certain regulatory loci (Richon et al., 2000; Iezzi et al., 2002) , supporting the presence of both acetyltransferases and deacetylases in close proximity within these regions. We explored the functional relationship between acetyltransferases and deacetylases in controlling the acetylation of the p21 promoter, which is regulated by both p300/CBP and HDACs, after functional HDAC inactivation by the deacetylase inhibitor TSA. We hypothesized that local hyperacetylation would be produced upon TSA exposure only if acetyltransferases and deacetylases are simultaneously recruited on the same promoter, since simple deacetylase inactivation would not be sufficient to increase histone acetylation, in the absence of an acetyltransferase. The acetylation of H4 histones within the region of the p21 promoter encompassing sequences responsive to p53 and MyoD was monitored by chromatin immunoprecipitation (ChIP) analysis, before and after exposure to TSA in muscle cells and fibroblasts. The p21 promoter is regulated by MyoD-recruited acetyltransferases in C2C12 cells (Puri et al., 1997a) , but not in 10T1/2 fibroblasts, which are devoid of MyoD. We observed a basal H4 acetylation of p21 promoter ( Figure 1a , lane 3; Figure 1b , lane 11), which correlated with constitutive low levels of expression of p21 in these cells (data not shown). Exposure to TSA, which induces p21 upregulation (Richon et al., 2000) , caused H4 hyperacetylation on p21 promoter (Figure 1a , compare lanes 3 and 4; Figure 1b , compare lanes 11 and 12), suggesting that both acetyltransferases and deacetylases are present in close proximity on this promoter. Indeed minimal levels of p300 and HDAC1 were found associated to the chromatin of the p21 promoter, by ChIP analysis, in basal conditions (Figure 1a , lanes 5 and 7; Figure 1b lanes 13 and 15). And the levels of chromatin-associated p300 and HDAC1 increased upon hyperacetylation caused by TSA exposure (Figure 1a , lanes 6 and 8; Figure 1b , lanes 14 and 16). It has been reported that histone hyperacetylation increases the affinity of the bromodomain of p300 (or other acetyltransferases) to the chromatin (Zeng and Zhou, 2002) . The increased association of HDAC1 to hyperacetylated histones indirectly suggests that p300 and HDAC1 might be part of the same chromatin-associated multiprotein complex.
We next assessed the functional impact of histone deacetylases on p300-dependent transcription. Studies employing Gal4 fusion proteins have revealed that p300 and CBP can activate transcription once artificially bound to the Gal4 DNA-binding domain (Yuan et al., 1996; Martinez-Balbas et al., 2000) . Transient transfection of Gal4p300 1-2414 (full length) activated a chromatin-integrated Gal4-Luc reporter in 3T3 fibroblasts, and exposure to the deacetylase inhibitor TSA augmented the activity of Gal4p300 1-2414 (Figure 1c  and d) . In contrast, TSA did not significantly affect the Gal4-Luc activation in the absence of Gal4p300 ( Figure  1c and d) , and the activity of a panel of Gal4p300 mutants, which are devoid of the C/H3 region (aa 1515-1998), was only marginally affected by TSA (Figure 1d ). Overexpression of HDAC1 reduced Gal4p300 1-2414-dependent transcription in a dose-dependent manner (Figure 1c ), but the activity of Gal4p300 mutants lacking the C/H3 region was again not affected by HDAC1 co-transfection (Figure 1d ). The C/H3 region is highly conserved in the functional ortholog of p300, the acetyltransferase CBP, whose transcriptional activity was also reduced by HDAC1 co-expression and enhanced by TSA exposure (Figure 1d ). These data suggest that deacetylases can influence the transcriptional activity of p300, and indicate that a fragment of p300 encompassing aa 1182-1926, and containing the C/H3 region, is a candidate for functional interaction with deacetylases. Importantly, the C/H3 region alone fused to the Gal4 (Gal4p300 1514-1922) did not stimulate transcription; rather it slightly decreased the basal levels of Gal4-Luc expression (Figure 1d ). HDAC1 did not significantly decrease, and TSA only marginally affected this activity ( Figure 1d ).
We therefore investigated if Gal4p300 could co-purify deacetylase activity in vivo after transient transfection, followed by immunoprecipitation with anti-Gal4 antibodies. To this purpose, HeLa cells were transfected with Gal4 alone or with Gal4p300 1-2414. Nuclear extracts from transfected cells were immunoprecipitated with either anti-Gal4 or anti-HDAC1 antibodies, as a control, and processed for a deacetylase assay. Tritiumlabeled acetylated histone H4 peptide was used as a substrate and deacetylase activity was indicated by the release of radioactivity from the histone H4 substrate. As shown in Figure 2a , Gal4p300 1-2414 could coprecipitate deacetylase activity, which was significantly higher than the background activity co-precipitated by the Gal4 alone, albeit lower than the activity coprecipitated with anti-HDAC1 antibodies, which was used as a positive control. Notably, a Gal4p300 1514-1922, which encompasses the C/H3 domain alone, was sufficient to co-precipitate deacetylase activity (Figure 2a ), indicating that the C/H3 domain is implicated in the recruitment of HDAC-like activity. No deacetylase activity was detected in the Figure 1 Regulation of p300-dependent transcription by deacetylases. (a,b) C2C12 myoblasts and CH310T1/2 fibroblasts were formaldehyde crosslinked and processed for ChIP with anti-acetyl histone H4 (Ac-H4), anti-HDAC1 and anti-p300, or no antibody (Àab), as control, for 4 h. PCRs were performed with primers for the mouse p21 promoter as described in Materials and methods. (c,d) A measure of 400 ng of the indicated Gal4 constructs was transfected into NIH-3T3 cells with integrated Gal4-Luc. Cells were exposed or not to TSA (50 nM), or increasing amounts of HDAC1 (400 and 800 ng), and were co-transfected. Cells were harvested and luciferase value determined. In (d), fold activations by Gal4-p300 and Gal4-CBP constructs are relative to the values of Gal4 alone. HDAC1 fold repression and TSA fold activation are relative to the transactivation values of the Gal4-p300 and Gal4-CBP constructs Interaction between histone acetyltransferases and deacetylases C Simone et al immunoprecipitates, when the deacetylase inhibitor sodium butyrate was added to the reaction ( Figure 2a ).
We gained further insight into the association between p300 and deacetylases by incubating nuclear HeLa extracts with a panel of sepharose-immobilized GSTp300 fragments. The enzymatic deacetylase activity associated with GST-p300 fragments was further revealed by a deacetylase assay. GST pRB, which interacts with HDAC1, was employed as a positive control in this assay ( Figure 2b ). Only those GST-p300 fragments, within the C-terminal region, that contain that C/H3 region (GST-p300-1572-2370 and 1752-1998) could precipitate histone deacetylase activity, to an extent comparable to the GST pRB control (Figure 2b ). In contrast, no deacetylase activity was associated with GST-p300 fragments, which do not contain the C/H3 region ( Figure 2b ). The specificity of this enzymatic reaction was confirmed by incubating the GST-purified complex with the deacetylase inhibitor sodium butyrate, which efficiently abolished the deacetylase activity associated to GST-p300-1572-2370 ( Figure 2c ). These data demonstrate that nuclear deacetylase activity can be associated to the C/H3 region of p300.
To investigate potential interactions between p300 and deacetylases, we sought to test the in vitro binding between p300 and a prototype of class I deacetylases, HDAC1, and define the binding domains involved in such an interaction. GST-p300 fusion proteins encompassing three distinct regions of p300 were incubated with in vitro translated S 35 -radiolabeled HDAC1. The interaction between GST-p300 fragments and in vitro translated HDAC1 was detected by S 35 autoradiography following GST-bead affinity purification. The N-terminal region (p300-1-569) as well as a region containing both bromodomain and HAT domain (p300-744-1572) did not interact with HDAC1. In contrast, the Cterminal region (p300-1572-2370), spanning the C/H3 domain, significantly associated with HDAC1 ( Figure 2d ). The same conclusion was supported by a set of experiments in which GST-HDAC1 was incubated Figure 2 Deacetylase recruitment by the p300 C/H3 region. (a) Gal4 alone (Gal4), Gal4-p300 full-length 1-2414 (Gal4p300 wt) and Gal4-p300-1514-1922 were transfected into HeLa cells. Nuclear extracts (400 mg) were immunoprecipitated with agarose-conjugated anti-Gal4 or -HDAC1 antibodies, as indicated. Immunoprecipitates were incubated with tritium-labeled acetylated histones H4 and assayed for deacetylase activity in the presence or not of 50 mM sodium butyrate (Bt). The data shown reflect representative sets of values of two experiments. (b) HeLa nuclear extracts (100 mg) were incubated with the indicated GST-purified proteins and then used for a deacetylase assay. (c) GST-p300-1572-2370 was treated as in (b), and 0, 20 and 50 mM sodium butyrate (Bt) added to the deacetylase assay. (d) GST-p300 fragments were incubated with in vitro transcribed (IVT) S 35 -labeled HDAC1. After GST-mediated purification and extensive washes, proteins were separated on polyacrylamide gels and visualized by autoradiography. (e) IVT S 35 -labeled p300 fragments were incubated with GST alone or GST-HDAC1. After GST-mediated purification and extensive washes, proteins were separated on polyacrylamide gels and visualized by autoradiography. (f) The indicated GST proteins were incubated with IVT S 35 -labeled HDAC1. After GST-mediated purification and extensive washes, proteins were separated on polyacrylamide gels and visualized by autoradiography. (g) Schematic representation of the GST-p300 constructs used in GST pull-down assay with HDAC1 and associated deacetylase activity Interaction between histone acetyltransferases and deacetylases C Simone et al with four S
35
-labeled p300 constructs, as indicated in Figure 2e . In agreement with the data presented in Figure 2d , only p300-1257-2414 and p300-1737-2414 fragments, both spanning the p300 C/H3 domain, associated with HDAC1, whereas p300-1-744 and p300-1869-2414 (flanking the C/H3 domain) failed to bind it (Figure 2e ). We further analysed the HDAC1-interacting domains within the p300 C-terminal region by using a panel of C/H3 internal deletion mutants as well as fragments encompassing C/H3 flanking regions (see GST-p300 fragments depicted in Figure 2g ). As shown in Figure 2f , a GST-p300 fragment including aa 1853-1942 was unable to interact with HDAC1. Deletion of C/H3 flanking regions in GST-p300-1515 GST-p300- -1998 GST-p300- , 1752 GST-p300- -1998 or 1752-1859 did not interfere with HDAC1 association (Figure 2f ). GST-pRB served as a positive control for the specificity of the HDAC1 binding in this assay. Thus, the p300 fragment containing aa 1752-1859, within the C/H3 region, is the minimal region for deacetylase recruitment (Figure 2g ).
The association between acetyltransferases and deacetylases was further tested in vivo, upon co-transfection of HA-tagged HDAC1 and p300 in COS-7 cells, followed by immunoprecipitation with anti-p300, anti-HA and anti-HDAC1 antibodies from the nuclear extracts. The presence of HDAC1 in the anti-p300 immunoprecipitates (Figure 3a, lane 1) , and of p300 in the anti-HDAC1 and anti-HA immunoprecipitates (Figure 3a , lanes 2 and 3) was revealed by Western blot using anti-p300 and anti-HA antibodies. As a positive control, anti-E1A antibodies could precipitate p300 from COS-7 cells, upon co-transfection of p300 and the p300-interacting protein E1A (Figure 3a, lane 4) .
The ability of deacetylases to interact with the C/H3 domain ( Figure 2 ) and to interfere with the transcriptional activity (Figure 1d ) of p300/CBP is reminiscent of Figure 3 Competition between HDAC1 and E1A for binding to p300. (a,b) HA-tagged HDAC1, pCDNA-p300 (5 mg each) and E1A (1, 2 or 3 mg) were overexpressed in COS-7 cells, and nuclear cell extracts were immunoprecipitated with agarose-conjugated anti-p300 (AG N-15 from Santa Cruz), agarose-conjugated antiHa (A2095 from Sigma), agarose-conjugated anti-HDAC1 (AG C-19 from Santa Cruz), anti-E1A (a mixture of M73 and M37) or control serum (preimmune). For Western blot, anti-Ha (F-7 from Santa Cruz) and anti-p300 (N15 from Santa Cruz) were used in panel a, and anti-Ha (F-7 from Santa Cruz), anti-p300 (N15 from Santa Cruz) and anti-E1A (M73) were used in panel b. (c) In all, 100 and 200 ng of purified E1A protein, as well as 200 ng of purified BSA, was incubated with GST-p300-1572-2370 in a GST precipitation assay to compete for the binding of 35 S-labeled HDAC1. (d) Baculovirus p300 purified from SF9 cells (recombinant p300) or endogenous p300 immunoprecipitated from Cos-7 cells were incubated with C 14 acetyl-CoA for an acetylation assay in the presence or not of TSA (100 nM). After the reaction, the material was loaded onto a 4-15% gradient gel and p300 autoacetylation was revealed by C 14 autoradiography (upper panel). An aliquot of the immunoprecipitated material was separately loaded onto a 4-15% gradient gel and transferred to nitrocellulose membrane, where p300 was revealed by Western blot with anti-p300 (N15 from Santa Cruz). (e) Nuclear extracts from Cos-7 cells were immunoprecipitated with the described antibodies, and immunoprecipitates were incubated with tritium-labeled acetylated histones H4 assayed for deacetylase activity in the presence or not of TSA. An aliquot of the immunoprecipitated material was separately loaded onto a 4-15% gradient gel and transferred to nitrocellulose membrane, where immunoprecipitated p300 was revealed by Western blot with anti-p300 (N15 from Santa Cruz). The data shown reflect representative sets of values of two experiments Interaction between histone acetyltransferases and deacetylases C Simone et al E1A ability to bind the C/H3 domain of p300 and inhibit p300-mediated co-activation of a wide array of transcription factors (Goodman and Smolik, 2000) . We conceived that HDAC1 might simulate E1A effect on p300/CBP by using similar mechanism of inhibition, that is, by interacting with the C/H3 domain. This hypothesis was first tested by a competition between HDAC1 and E1A for interaction with p300 upon cotransfection in Cos-7 cells (Figure 3b) . In this context, increasing concentrations of ectopically expressed E1A could displace p300-HDAC1 interaction (Figure 3b , compare lane 1 to lanes 2-4). An E1A mutant impaired in associating with p300 failed to disrupt HDAC1-p300 interaction (data not shown). The competition between E1A and HDAC1 for C/H3 binding was further tested in an in vitro pull-down assay, using a GST-p300-1572-2370, in vitro translated 35 S-radiolabeled HDAC1 and increasing doses of recombinant E1A. Again, increasing concentrations of E1A reduced HDAC1 binding to the GST-p300 1572-2370 (Figure 3c ), thus indicating that HDAC1 and E1A use the same or an overlapping region of p300 for interaction.
One predictable consequence of the interaction between p300 and deacetylases is that the autoacetylation of p300 could be counteracted by the associated deacetylase(s). We tested this hypothesis by performing an autoacetylation assay upon immunoprecipitation of p300 from COS-7 cell nuclear extracts. Immunoprecipitated p300 was incubated with C 14 acetyl-CoA in the presence or not of a large excess of the deacetylase inhibitor TSA, and the extent of autoacetylation was revealed by C 14 incorporation. Deacetylase inhibition by TSA enhanced the autoacetylation of p300 immunoprecipitated from nuclear extracts (Figure 3d , compare lanes 3 and 4), consistent with the association of deacetylases regulating the acetylation status of p300. Importantly, autoacetylation of recombinant p300 purified from baculovirus-infected SF9 cells was not influenced by TSA incubation (Figure 3d, lanes 1 and 2) , consistent with the absence of deacetylases associated with highly purified p300. The deacetylase activity associated to endogenous p300 was also measured in a deacetylation assay after immunoprecipitation of p300 from the nuclear extracts of Cos-7 cells. In this assay, immunoprecipitated p300 revealed a twofold higher deacetylase activity as compared to the background activity precipitated by IgG of control (Figure 3e ). Inclusion of TSA in the reaction eliminated the deacetylase activity associated to p300 or HDAC1 (used as a positive control), but did not affect the background activity associated to IgG (Figure 3e) .
The results reported in Figure 3 collectively suggest that, in analogy with E1A, the recruitment of deacetylases by the C/H3 domain disrupts the function of p300 as a co-activator for sequence-specific transcription factors. It has been previously reported that transcriptional activation engendered by the acidic activation domain carrying VP16 protein depends on p300 (Kraus et al., 1999) . Accordingly, co-expression of p300 increased VP16-dependent transcription about 2.5-fold (Figure 4a) . And co-expression of HDAC1 caused a marked inhibition of Gal4-Luc basal transcription stimulated by Gal4VP16 (Figure 4a ). A direct crosstalk between p300 and HDAC1 implies that relative expression levels mutually influence each other's activity. In agreement with this notion, an increasing amount of transfected p300 rescued the HDAC1-meditated repression on Gal4VP16 with an efficiency comparable to the inactivation of HDAC1 by TSA (Figure 4a ). We then investigated the effect of HDAC1 in biologically relevant contexts, such as p300-dependent activation of MyoD, which triggers skeletal muscle differentiation, and p53, which mediates induction of genes involved in both cell cycle arrest and apoptosis. Previous reports have shown that, like E1A, HDAC1 can suppress either MyoD-or p53-dependent transcription (Luo et al., 2001; Mal et al., 2001; Puri et al., 2001) . In Figure 4b , it is shown that forced expression of HDAC1 counteracted p300-dependent transcription from MyoD. Likewise, HDAC1 overexpression could reduce p300-mediated co-activation of p53-dependent transcription (Figure 4c ). In analogy with E1A-mediated repression of transcription, increasing amounts of relative p300 levels were able to relieve transcriptional repression of either MyoD or p53 caused by HDAC1 overexpression, with an efficiency comparable to HDAC1 inhibition by TSA exposure (Figure 4a-c) . The fact that an increasing amount of transfected p300 could restore MyoD-and p53-dependent transcription in the presence of HDAC1 suggests that HDAC1 can functionally compete with p300-mediated activation of MyoD-or p53-dependent transcription.
Previous studies reported that p300 mutant encompassing aa , that is, the C/H3 region insulated from the rest of the molecule, can act as a dominantnegative molecule (C/H3 dn), which represses MyoDand p53-dependent transcription (Yuan et al., 1996; Avantaggiati et al., 1997; Puri et al., 1997a) . We postulated that deacetylase recruitment by the C/H3 region of p300 could account for the dominant-negative effect of C/H3. To test this hypothesis, we evaluated if inhibition of HDAC activity by deacetylase inhibitors could reverse the dominant-negative effect of C/H3 dn. p53 was expressed in SAOS cells by transient transfection, along with a luciferase reporter containing multiple p53-responsive sites, with or without co-transfection of C/H3 dn. The reporter activation was measured in the presence or absence of TSA and butyrate (Figure 5a) . Likewise, the transcriptional activity of the endogenous MyoD in C2C12 cells was monitored by transient transfection of the muscle-specific reporter MCK-Luc with or without co-transfection of C/H3 dn, in the presence or absence of TSA or butyrate (Figure 5b ). Cotransfection of C/H3 dn could repress both p53-and MyoD-dependent transcription (Figure 5a and b) . Deacetylase inhibition by TSA or butyrate rescued the C/H3-dependent repression (Figure 5a and b) , indicating that the dominant-negative effect of C/H3 dn on p53 and MyoD is largely dependent on deacetylase recruitment. By contrast, E1A-dependent inhibition of p53-and MyoD-dependent transcription was not reverted by TSA or butyrate, indicating that the effect of TSA on C/H3 dn was specifically attributable to deacetylase inhibition. Likewise, deacetylase inhibitors failed to rescue the inhibition of MCK-Luc by another p300 dominant-negative molecule (p300-1869-2414) (Sartorelli et al., 1997), which does not contain the HDACbinding region. Notably, TSA and butyrate repressed MCK-Luc activity (Figure 5b ) and myotube formation (Johnston et al., 1992) in C2C12 incubated in differentiation medium; however, they promote MCK-Luc activity and stimulate myotube formation when the exposure is restricted to proliferating undifferentiated myoblasts (Iezzi et al., 2002) , that is, when MyoD and HDAC1 associate .
The results reported in this study support the notion that acetyltransferases can control transcription also by recruiting deacetylase activity (or vice versa), and underscore a further degree of complexity in the mechanism of transcriptional regulation by acetylation/deacetylation. The same notion can be extrapolated by recent reports showing an association between CBP and Sir2 (Newman et al., 2002) , p300 and HDAC6 (Girdwood et al., 2003) , and between PCAF and HDAC1 (Yamagoe et al., 2003) . Yamagoe et al. (2003) identified PCAF, but not p300 or CBP, as a component of an HDAC1-associated complex that was purified from HeLa cells. We have also failed to detect an association between endogenous HDACs and p300/ CBP in nuclear extracts from HeLa cells or other cell lines expressing viral oncoproteins, possibly because of the competition for C/H3 binding between HDACs and viral proteins expressed by HeLa cells (see Figure 3) . However, we have used HeLa nuclear extracts to demonstrate deacetylase recruitment in vitro by the C/H3 region of p300 (Figure 2) . It is possible that in these in vitro assays, the large amounts of nuclear extracts, and recombinant or transfected p300 proteins we used, overcame any competition by endogenous human papillomavirus proteins from HeLa. Notably, a deacetylase activity associated to endogenous p300 was detectable in Cos-7 cells, and was eliminated by incubation with TSA (Figure 3e) . The finding that a C/ H3-binding protein (PCAF) interacts with HDAC1 (Yamagoe et al., 2003) also suggests the possibility that PCAF could mediate deacetylase recruitment by p300/ CBP. However, the failure to detect p300/CBP in both HDAC1-associated (Yamagoe et al., 2003) and PCAFassociated complexes in HeLa cells appears to contradict this possibility.
The recruitment of HDAC-like activity by p300 and the negative interference of HDAC1, a prototype histone deacetylase, with the function of p300 appear in strong analogy to the modalities of inhibition by the oncoprotein E1A. Like a plethora of factors, HDAC1 binds to the C/H3 domain of p300, and E1A competes with HDAC1 for C/H3 binding. We have shown that, like E1A, HDAC1 overexpression represses Figure 4 HDAC1 negatively interferes with p300-mediated transcription. (a) Gal4-VP16 (200 ng) was co-transfected with Gal-Luc reporter and CMV-Gal (300 ng each) into NIH-3T3 cells using lipofectamine. HDAC1 (800 ng) and p300 (300 and 600 ng) were co-transfected as indicated. (b) pCMV-MyoD (1 mg) (see expression levels of transfected MyoD by Western blot in the inset), or (c) pCMV-p53 (1 mg) were co-transfected with 4RE-Luc or p53-Luc reporters, respectively, and CMV-Gal (1 mg each) into NIH-3T3 cells using standard calcium phosphate technique. HDAC1 (2 mg) and p300 (2 and 4 mg) were co-transfected as indicated. Luciferase activity was adjusted to b-Gal activity. TSA (50 nM) was added to cell cultures when indicated. Values presented reflect averages of at least two sets of experiments performed in triplicate Interaction between histone acetyltransferases and deacetylases C Simone et al p300-mediated co-activation of at least two transcription factors -MyoD and p53 -whose activation is dependent on binding to the p300 C/H3 domain. It is possible that other deacetylases may interact with the C/H3 domain of p300 and account for the deacetylase activity associated to this region. Despite E1A and HDAC1 (or other deacetylases) share the binding for the C/H3 region of p300, they appear to counter p300 activity using different mechanisms. Deacetylasemediated inhibition of p300, and by extension the dominant-negative effect of C/H3 are reversed by deacetylase inhibitors, while E1A-dependent repression of p300 activity is refractory to deacetylase inhibitors (see Figures 4 and 5) .
How does HDAC recruitment by p300 regulate the function of these transcription factors and which functional significance can be attributed to this complex? Given their opposite roles in regulating transcription, the interaction between acetyltransferases and deacetylases might appear paradoxical. However, it should be noted that rapid changes in global and local histone acetylation have been observed in yeast and eucaryotes; and the concomitant presence of acetyltransferases and deacetylases, possibly in one complex, might explain such rapid fluctuations in promoter acetylation.
Deacetylase recruitment by a transcriptional coactivator, such as p300/CBP, can be viewed in several functional contexts. For instance, it might prevent engagement by p300/CBP of additional activatory proteins, such as PCAF, at transcription silent loci. In this event, the simultaneous presence of acetyltransferases and deacetylases on regulatory regions of certain genes might impose a constitutive promoter deacetylation when transcription has to be silenced. A rapid acetylation of the same promoters could be allowed by specific cues that stimulate HAT and/or inhibit deacetylase activity. In our experimental conditions, we have used the deacetylase inhibitor TSA to validate this hypothesis (see Figure 1) . Possibly, the simultaneous recruitment of p300 and HDACs might provide a finetuning regulation of those genes whose expression fluctuates during the cell cycle (e.g. p21), as suggested by our data. Alternatively, recruitment of deacetylase activity by p300/CBP might serve as a negative feedback mechanism to attenuate the initial burst phase of transcription. In this case, it could be predicted that deacetylase activity would be implicated in restoring the original configuration of chromatin. According to these predictions, deacetylase recruitment might be implicated in the spatial and temporal control of transcription. Our experiments suggest that p300/ HDAC complex is involved in the regulation of both MyoD-and p53-dependent activation of gene transcription and, by extension, is implicated in the control of myogenesis and the cellular responses to genotoxic stress (e.g. activation of cell cycle checkpoints and apoptosis). Previous studies have revealed that both MyoD and p53 can recruit class I deacetylases, and this correlates with transcriptional repression. However, whether HDAC1 interaction with these transcriptional regulators is direct or not has never been clarified. For instance, both p300-MyoD and HDAC1-MyoD complexes can be detected in myoblasts, a stage in which MyoD is inactive (Luo et al., 2001; Newman et al., 2002; Girdwood et al., 2003) . It is possible that at this stage, HDAC1 assembles MyoD-p300 in one transcriptionally inert complex. Physical or functional displacement of HDAC1, and replacement by PCAF, would confer to this complex transcriptional competence. Moreover, acetyltransferases and deacetylases might reciprocally modulate their enzymatic activity by cross-acetylation and deacetylation, although further studies need to clarify the dynamics of these interactions. (a) p53 (300 ng), p300-C/H3 dn (500 ng) and E1A (500 ng) were cotransfected with p53-Luc and Renilla-NULL-Luc reporters in SAOS-2 cells using lipofectamine. TSA (50 nM) and butyrate (Btr) (5 mM) were added to the medium as indicated. (b) p300-C/H3 dn (500 ng), p300-1869-2414 (500 ng) and E1A (500 ng) were cotransfected with MCK-Luc and Renilla-NULL-Luc reporters in C2C12 cells. TSA (50 nM) and Btr (50 mM) were added to the medium as indicated. Cells were collected and luciferase activity was measured using dual luciferase kit. Values presented reflect averages of experiments performed in triplicate Interaction between histone acetyltransferases and deacetylases C Simone et al
The findings that nuclear histone deacetylase activity associates with the C/H3 region of p300 also turned our interest toward the biological effect of the C/H3 fragment. The C/H3 fragment insulated from the rest of the molecule has been reported to act as a dominantnegative mutant (Yuan et al., 1996; Avantaggiati et al., 1997; Puri et al., 1997b) , but the molecular mechanism for such activity has not been elucidated. The repression of transcription mediated by C/H3-binding proteins, such as p53, MyoD and E2F1, has previously been attributed to the ability of C/H3 to titrate these proteins away from endogenous p300. However, we have also observed a C/H3 dn-mediated repression of transcription driven by factors binding regions of p300/CBP distinct from the C/H3 domain, for example, CREB (data not shown). The relief of C/H3-mediated repression imposed by the exposure to deacetylase inhibitors suggests the importance of deacetylase recruitment in mediating the dominant-negative effect of C/H3. Since C/H3 interacts with the components of the basal transcription machinery (Nakajima et al., 1997; Cho et al., 1998; Kim et al., 1998; Felzien et al., 1999) , we propose that overexpressed C/H3 can recruit deacetylase activity on transcription-competent complexes, and therefore functions as a global repressor of p300/CBPdependent transcription. Given the relevance of deacetylases and acetyltransferase in controlling gene expression during normal cell function, their deregulation in a variety of pathological conditions and the possibility to target their enzymatic activity by specific compounds, the physical and functional interactions between these enzymes, might have interesting physiological implications.
Materials and methods

Plasmids
GST constructs GST-p300-1-569, GST-p300-744-1571, GST-p300-1572-2370 and the plasmid p300-1869-2414dn are described in Sartorelli et al. (1997) . GST-p300-1752 -1859 , GST-p300-1752 , GST-p300-1515 and GST-p300-1853 -1942 were provided by Dr Mink and Dr Klempnauer. GST-pRB 372-928 was described in Stiegler et al. (1998) . The HDAC-1 cDNA was generated by PCR (primers for HDAC1 cDNA cloning: GGATCCAAGCTTATGGCGCAGACG CAG and GGATCCCGGGTCAGGCCA-ACTTGACCTC) and subcloned into pGEX-2T (Stratagene) and pFLAG-CMV-2 (Kodak) vectors. pCMV-HA-HDAC1 was provided by Harel-Bellan. The Gal4-responsive luciferase reporter pG5E1B-Luc, the MyoD-responsive reporter 4RE-Luc and MCK-Luc, the activators pcDNA-Gal4, pcDNA-Gal4-VP16, pCMV-MyoD, pBS-p300-1-744, pBS1257-2414, pBS-1869-2414, and Gal4Luc reporter are described in Sartorelli et al. (1997) and Hamamori et al. (1999) . pcDNA-Gal4-p300 611-2287 and pcDNA-Gal4-p300 611-1284 were provided by Dr LaThangue. GST-E1A, pcDNA-E1A, pCMV-p53 and p53-responsive promoter p53-Luc were described in Sang et al. (1997) . The plasmids pcDNA-Gal4-p300-1-2414, pcDNA-Gal4-p300-1926-2414 and pcDNA-p300-1514-1922 (C/H3dn) were described in Yuan et al. (1996) . Gal4CBP was provided by Dr Montminy. pCMV-b-Gal was from Promega.
Cell culture and transfection
For transfection, C2C12, 10T1/2, Cos-7, HeLa and SAOS cells were cultured in DMEM supplemented with 10% FBS (Gibco-BRL) and NIH 3T3 supplemented with 10% CS (Gibco-BRL). Transfections were carried out with the calcium phosphate method or with lipofectamine. Luciferase activity was determined with a Promega Luciferase kit and normalized by either b-Gal values or using the dual luciferase reporter assay system (Promega). 3T3 cells with Gal4-uc integrated were generated by transfecting the Gal4-Luc reporter together with pcDNA3-Neo R and selection for G418-resistant clones. Antibioticresistant colonies were combined to yield a polyclonal population of reporter cells. Sodium butyrate 5 mM (Sigma) and trichostatin A 50 nM (Upstate Biotechnologies) were added to cell cultures when indicated.
GST purification assay and in vitro protein/protein interactions GST protein preparation, in vitro transcription-translation (IVT; kit by InVitroGen), polyacrylamide gel electrophoresis (PAGE) and autoradiography were performed as described earlier (Stiegler et al., 1998) . For binding assays, 35 S-IVT proteins were incubated with 1 g of the indicated GST fusion proteins at 41C for 2 h, washed 3 Â in buffer A and subjected to PAGE and autoradiography. For the competition assay, E1A was expressed as a GST fusion protein. Glutathione agarose bead purified GST-E1A was digested with thrombin (Sigma) and E1A in the supernatant was dialysed against 1 Â NENT. The radiolabeled HDAC1 and E1A or BSA were co-incubated with GST-p300.
Chromatin immunoprecipitation
A ChIP assay was performed using the anti-acetyl-histone H4 (Upstate Biotechnology), the anti-HDAC1 (Upstate Biotechnology) and the anti-p300 (N-15 Ac, Santa Cruz) antibodies according to Upstate Biotechnology instructions. PCR was performed on 'input' DNA of different samples, and equivalent amounts of immunoprecipitated DNA were amplified by PCR using primers for the mouse p21 promoter. Primers for the mouse p21 promoter are as follows: forward 5 0 GAG GAT ACC TTG CAA GGC TGC A 3 0 ; reverse 5 0 GCA CAC CAT TGC ACG TGA ATG T 3 0 . PCR conditions were 1 Â 951C for 2 min, followed by 25 cycles at 951C for 30 s, 601C for 30 s and 721C for 30 s.
Deacetylase assay
We used a Histone Deacetylase Assay Kit (Upstate Biotechnology). A 20-amino-acid long histone H4 peptide (corresponding to the H4 N-terminus) was chemically labeled with 3 H-acetic acid following the manufacturer's protocol. HeLa or Cos-7 nuclear extracts were incubated with 2 mg of the indicated GST fusion proteins for 2 h at 41C or with agarose-conjugated anti-HDAC1 (AG C-19 from Santa Cruz), anti-p300 (AG N15 Ac, Santa Cruz) and anti-Gal4 (Santa Cruz) antibodies (4 h at 41C). The immunoprecipitates were processed for deacetylation assay as described in Puri et al. (2001) . Deacetylase activity was measured from the release of 3 H radioactivity from the histone H4 substrate.
Immunoprecipitation and immunoblotting
Nuclear cell extracts and immunoprecipitations were performed as described previously (Stiegler et al., 1998; Puri et al., 2001 ). For co-immunoprecipitation studies, nuclear extracts were precleared with an A þ G sepharose mix for 30 min at 41C and immunoprecipitated with agarose-conjugated anti-HDAC1 (AG C-19 from Santa Cruz), anti-p300 (AG N15 Ac, Santa Cruz), anti-HA (A2095 from Sigma) and anti-E1A (mixture of M73 and M37 antibodies) (4 h at 41C).
Immunoprecipitates were extensively washed with the lysis buffer, resuspended in Laemmli buffer, separated on polyacrylamide gels and transferred to nitrocellulose membranes, and precipitated proteins were revealed by ECL system (NEN Life Sciences). Western blots were revealed by ECL after protein transfer to nitrocellulose membranes and incubation with anti-p300 (N15 Ac, Santa Cruz), anti-HA (F7 from Santa Cruz) and anti-E1A (M73) antibodies. Detection by Western blot of transfected MyoD was performed by using anti-MyoD antibody (318, Santa Cruz).
Acetylation assay
Autoacetylation of immunoprecipitated p300 or recombinant p300 purified from baculovirus infected SF9 cells was performed by in vitro acetylation assay as described in Sartorelli et al. (1999) .
